This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Pressure Biosciences
5/19/2021
Greetings. Welcome to the Pressure Biosciences first quarter investor conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Rich Schumacher, CEO of Pressure Biosciences. Mr. Schumacher, you may begin.
Thank you, Alex. Welcome everybody to our first quarter 2021 financial review and business update. Before we begin, I would like to read a short statement. The following remarks may constitute forward-looking statements within the meaning of Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, among others, those detailed from time to time in the company's filings with the Securities and Exchange Commission. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statement is based. So today in the agenda, the first thing I'd like to do is is, uh, announced that once again, I'm very pleased, uh, to welcome Jeff Peterson to our call. Jeff, as I'm sure most everybody knows, uh, is our chairman of the board. Uh, and he is a, uh, a terrific chairman. I've said this oftentimes at, uh, that all public companies should be blessed to have sound like Jeff, uh, running the board and helping with the company. So Jeff, I've asked Jeff to come here today to help answer some of the questions. to offer his insight, which is sometimes not exactly the same as mine, but often is, on the progress we've made over the past three months and to discuss what we consider to be our exciting future. Jeff, welcome today.
Good afternoon, everybody. It's always a pleasure to join you.
You're reading a preview of the PBIO Q1 2021 earnings call.
Free account.